Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
49.10
+1.43 (3.00%)
Nov 22, 2024, 4:00 PM EST - Market closed
Cytokinetics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 46.89 | 113.02 | 65.58 | 112.67 | 82.99 | 36.43 | Upgrade
|
| Short-Term Investments | 964.8 | 501.8 | 717 | 358.97 | 381.08 | 188.68 | Upgrade
|
| Cash & Short-Term Investments | 1,012 | 614.82 | 782.58 | 471.64 | 464.06 | 225.11 | Upgrade
|
| Cash Growth | 87.61% | -21.44% | 65.93% | 1.63% | 106.15% | 13.27% | Upgrade
|
| Accounts Receivable | 0.24 | 1.28 | 0.15 | 56.82 | 6.92 | 5.16 | Upgrade
|
| Receivables | 0.24 | 1.28 | 0.15 | 56.82 | 6.92 | 5.16 | Upgrade
|
| Prepaid Expenses | 6.67 | 11.94 | 12.46 | 7.22 | 3.24 | 3.48 | Upgrade
|
| Total Current Assets | 1,019 | 628.05 | 795.19 | 535.67 | 474.22 | 233.75 | Upgrade
|
| Property, Plant & Equipment | 140.57 | 147.74 | 163.19 | 146.41 | 16.27 | 13.41 | Upgrade
|
| Long-Term Investments | 269.17 | 40.53 | 46.71 | 152.05 | 36.95 | 42.65 | Upgrade
|
| Other Long-Term Assets | 7.73 | 8 | 9.69 | 7.19 | 6.36 | - | Upgrade
|
| Total Assets | 1,436 | 824.32 | 1,015 | 841.32 | 533.8 | 289.81 | Upgrade
|
| Accounts Payable | 11.58 | 21.51 | 25.61 | 21.09 | 8.05 | 8.16 | Upgrade
|
| Accrued Expenses | 49.83 | 42.64 | 44.1 | 34.37 | 19.32 | 12.12 | Upgrade
|
| Current Portion of Long-Term Debt | 11.52 | 10.08 | 0.96 | - | - | - | Upgrade
|
| Current Portion of Leases | 18.86 | 18.88 | 12.83 | 14.86 | 2.79 | 4.62 | Upgrade
|
| Other Current Liabilities | 18.03 | 9.57 | 1.12 | 1.54 | 1.05 | 1.12 | Upgrade
|
| Total Current Liabilities | 109.81 | 102.68 | 84.62 | 71.86 | 31.2 | 26.02 | Upgrade
|
| Long-Term Debt | 763.1 | 607.37 | 609.62 | 142.84 | 135.71 | 129.26 | Upgrade
|
| Long-Term Leases | 114.75 | 120.58 | 126.9 | 112.23 | 0.44 | 2.2 | Upgrade
|
| Long-Term Unearned Revenue | 448.51 | 379.98 | 300.5 | 266.07 | 253.07 | 143.28 | Upgrade
|
| Other Long-Term Liabilities | 13.8 | 0.03 | 1.04 | 4.46 | - | - | Upgrade
|
| Total Liabilities | 1,450 | 1,211 | 1,123 | 597.46 | 420.42 | 300.75 | Upgrade
|
| Common Stock | 0.12 | 0.1 | 0.09 | 0.08 | 0.07 | 0.06 | Upgrade
|
| Additional Paid-In Capital | 2,532 | 1,726 | 1,482 | 1,452 | 1,105 | 853.34 | Upgrade
|
| Retained Earnings | -2,552 | -2,112 | -1,586 | -1,208 | -992.31 | -865.02 | Upgrade
|
| Comprehensive Income & Other | 5.39 | -0.01 | -3.59 | -0.87 | 0.15 | 0.68 | Upgrade
|
| Shareholders' Equity | -13.91 | -386.32 | -107.9 | 243.86 | 113.38 | -10.94 | Upgrade
|
| Total Liabilities & Equity | 1,436 | 824.32 | 1,015 | 841.32 | 533.8 | 289.81 | Upgrade
|
| Total Debt | 908.23 | 756.91 | 750.3 | 269.93 | 138.94 | 136.07 | Upgrade
|
| Net Cash (Debt) | 103.47 | -142.09 | 32.28 | 201.71 | 325.12 | 89.04 | Upgrade
|
| Net Cash Growth | - | - | -84.00% | -37.96% | 265.13% | -42.75% | Upgrade
|
| Net Cash Per Share | 0.96 | -1.47 | 0.36 | 2.62 | 5.04 | 1.55 | Upgrade
|
| Filing Date Shares Outstanding | 118.01 | 103 | 95.16 | 84.86 | 71.11 | 59.45 | Upgrade
|
| Total Common Shares Outstanding | 117.89 | 101.64 | 94.83 | 84.8 | 71.02 | 59.17 | Upgrade
|
| Working Capital | 908.79 | 525.37 | 710.57 | 463.81 | 443.02 | 207.73 | Upgrade
|
| Book Value Per Share | -0.12 | -3.80 | -1.14 | 2.88 | 1.60 | -0.18 | Upgrade
|
| Tangible Book Value | -13.91 | -386.32 | -107.9 | 243.86 | 113.38 | -10.94 | Upgrade
|
| Tangible Book Value Per Share | -0.12 | -3.80 | -1.14 | 2.88 | 1.60 | -0.18 | Upgrade
|
| Machinery | - | 28.16 | 28.45 | 27.48 | 22.99 | 23.5 | Upgrade
|
| Construction In Progress | - | 0.22 | 0.74 | 0.22 | 9.13 | - | Upgrade
|
| Leasehold Improvements | - | 66.87 | 65.91 | 60.34 | 5.87 | 5.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.